Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions
Dimitrios Stefanoudakis(APLA Health), Panagiotis Christopoulos(National and Kapodistrian University of Athens), Alkis Matsas(National and Kapodistrian University of Athens), Εleni Stamoula(Aristotle University of Thessaloniki), Georgia Anna Katsampoula(Hippocration General Hospital), Evaggelia Karopoulou(National and Kapodistrian University of Athens), Ermioni Tsarna(National and Kapodistrian University of Athens)
Cited by 25
Related Papers
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
|Current Issues in Molecular Biology|2024|78
VEGF inhibition in urothelial cancer: the past, present and future
|World Journal of Urology|2020|19
The Evolving Landscape of Antibody–Drug Conjugates for Urothelial Carcinoma
|Clinical Genitourinary Cancer|2020|10